U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07768228) titled 'The Effect of L-Carnitine on Wound Healing in Patients With Diabetic Foot Ulcer.' on July 18.
Brief Summary: Primary outcome: To evaluate the efficacy of L-Carnitine supplementation on length and depth ulcer size
Secondary outcome: To investigate the effect of L-Carnitine supplements on:
1. Vascular endothelial growth factor (VEGF)
2. Inflammatory markers TNF-a (Tumor necrosis factor alpha).
3. Hemoglobin A1C (HbA1c) And Lipid profile (cholesterol, triglycerides, high-density Lipoprotein (HDL) and low-density lipoprotein (LDL)).
4. To assess the type and likelihood of any adverse drug reaction that can be related to L-Carnitine...